Holdings Information

Bibliographic Record Display

• Title:Medical isotope production without highly enriched uranium / Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies.
  
•    
• Corporate Author/Creator:National Research Council (U.S.). Committee on Medical Isotope Production Without Highly Enriched Uranium.
  
• Published/Created:Washington, D.C. : National Academies Press, ©2009.
  

• Holdings

  Holdings Record Display

  • Location:MAA LIBRARY (IKB) stacksWhere is this?
    
  • Call Number: QD181.U7 N385 2009
    
  • Number of Items:1
    
  • Status:Available
    

   
• Library of Congress Subjects:Uranium--Isotopes--Therapeutic use.
  Highly enriched uranium--Isotopes--Therapeutic use.
  Molybdenum--Isotopes--Therapeutic use.
  Technetium--Isotopes--Therapeutic use.
  Radioisotopes--Therapeutic use.
  Nuclear medicine--Standards--United States.
  
• Medical Subjects: Technetium--supply & distribution.
  Molybdenum--supply & distribution.
  Radioisotopes--supply & distribution.
  Uranium.
  Nuclear Reactors--legislation & jurisprudence.
  Nuclear Reactors--economics.
  United States.
  
• Description:xviii, 202 pages : illustrations (some color) ; 23 cm.
  
• Summary:"This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply."
  
• Additional formats:Also available in Open Book format via the National Academies Press home page.
  
• Notes:Includes bibliographical references.
  
• ISBN:0309130395 (pbk.)
  9780309130394 (pbk.)
  
• Contents:Background and study task
  Molybdenum-99/Technetium-99m production and use
  Molybdenum-99/Technetium-99m supply
  Molybdenum-99/Technetium-99m supply reliability
  Molybdenum-99/Technetium-99m demand
  Molybdenum-99/Technetium-99m production costs
  Conversion to LEU-based production of Molybdenum-99: technical considerations
  Conversion to LEU-based production of Molybdenum-99: regulatory considerations
  Conversion to LEU-based production of Molybdenum-99: general approaches and timing
  Conversion to LEU-based production of Molybdenum-99: prospects and feasibility.